packageIrsogladine

irsogladine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Irsogladine is an anti-ulcer drug intended for peptic ulcer and other acid-related stomach disorders, and has also been described as an anticarcinogenic and radiation-protective agent. It is considered investigational and is not an approved medicine in the European Union.

Summary written by glm-5.3-flash from Wikidata Q15634081 and the WHO ATC classification; not checked by a person.

name:irsogladine
ATC codes:A02BX16
DrugBank:DB13056
PubChem CID:3752
ChEBI:93307
Wikidata:Q15634081
formula:C9H7Cl2N5
molar mass:256.09 g/mol (PubChem CID 3752)
logP:2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown